What does Dr. I. Ameloot, Orthopedische heelkunde do?

Dr. I. Ameloot, Orthopedische heelkunde is a specialist medical practice in Gent. Private Limited, started on 26 October 1999, 1 establishment.

What is the address of Dr. I. Ameloot, Orthopedische heelkunde?

The registered office of Dr. I. Ameloot, Orthopedische heelkunde is located at Asselsstraat 100, 9031 Gent.

Is Dr. I. Ameloot, Orthopedische heelkunde still active?

Yes. According to the CBE (30 October 2026) Dr. I. Ameloot, Orthopedische heelkunde is active, legal situation “Normale toestand”, started on 26 October 1999.

Is Dr. I. Ameloot, Orthopedische heelkunde registered on Peppol?

Yes, Dr. I. Ameloot, Orthopedische heelkunde is registered on the Peppol network with ID 0208:0467137152.

What is the enterprise number of Dr. I. Ameloot, Orthopedische heelkunde?

The enterprise number of Dr. I. Ameloot, Orthopedische heelkunde is BE0467137152.

When was Dr. I. Ameloot, Orthopedische heelkunde founded?

Dr. I. Ameloot, Orthopedische heelkunde was founded on 26 October 1999.

Who are the directors of Dr. I. Ameloot, Orthopedische heelkunde?

According to the 2025 annual accounts, the directors of Dr. I. Ameloot, Orthopedische heelkunde are: Ivan Ameloot.

Is Dr. I. Ameloot, Orthopedische heelkunde a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 October 1999; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. I. Ameloot, Orthopedische heelkunde make in 2025?

Dr. I. Ameloot, Orthopedische heelkunde posted a profit after taxes of € 220,935 in financial year 2025.

What is the revenue of Dr. I. Ameloot, Orthopedische heelkunde?

As a small company, Dr. I. Ameloot, Orthopedische heelkunde is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 367,858.

Dr. I. Ameloot, Orthopedische heelkunde (Private Limited)

Dossier Dr. I. Ameloot, Orthopedische heelkunde, printed on 30 October 2026 from databakkes.be/en/0467137152/dr-i-ameloot-orthopedische-heelkunde. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 25 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. I. Ameloot, Orthopedische heelkunde from Gent, company number BE0467137152, closed financial year 2025 with a result of € 220,935 after tax. For that financial year Dr. I. Ameloot, Orthopedische heelkunde recorded a gross margin of € 367,858 and equity of € 2.7 million. Compared with financial year 2024, the result moved from € 268,056 to € 220,935. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.

What it is worth Growing

€ 2.7 million

▲ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 220,935

▼ 18% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 68,521

▼ 87% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 2.7 million.

People and assets in 2025

Vehicles and equipment

€ 97,827

▼ 28% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 13,438

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 8,145

▼ 28% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 51,899

▲ 74% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 409,184 Gross margin 2022: € 409,184 First fiscal year in the series	€ 333,164 Gross margin 2023: € 333,164 ▼ 19% vs 2022 (€ 409,184) Unfavourable step	€ 402,806 Gross margin 2024: € 402,806 ▲ 21% vs 2023 (€ 333,164) Favourable step	€ 367,858 Gross margin 2025: € 367,858 ▼ 9% vs 2024 (€ 402,806) Unfavourable step	▼ 9%
Profit after taxes	€ 245,924 Profit after taxes 2022: € 245,924 First fiscal year in the series	€ 202,128 Profit after taxes 2023: € 202,128 ▼ 18% vs 2022 (€ 245,924) Unfavourable step	€ 268,056 Profit after taxes 2024: € 268,056 ▲ 33% vs 2023 (€ 202,128) Favourable step	€ 220,935 Profit after taxes 2025: € 220,935 ▼ 18% vs 2024 (€ 268,056) Unfavourable step	▼ 18%
Equity	€ 2,016,128 Equity 2022: € 2,016,128 First fiscal year in the series	€ 2,218,255 Equity 2023: € 2,218,255 ▲ 10% vs 2022 (€ 2,016,128) Favourable step	€ 2,486,312 Equity 2024: € 2,486,312 ▲ 12% vs 2023 (€ 2,218,255) Favourable step	€ 2,707,247 Equity 2025: € 2,707,247 ▲ 9% vs 2024 (€ 2,486,312) Favourable step	▲ 9%
Total debts	€ 1,104,843 Total debts 2022: € 1,104,843 First fiscal year in the series	€ 1,169,775 Total debts 2023: € 1,169,775 ▲ 6% vs 2022 (€ 1,104,843) Unfavourable step	€ 1,200,831 Total debts 2024: € 1,200,831 ▲ 3% vs 2023 (€ 1,169,775) Unfavourable step	€ 1,279,160 Total debts 2025: € 1,279,160 ▲ 7% vs 2024 (€ 1,200,831) Unfavourable step	▲ 7%
Cash	€ 2,918,741 Cash 2022: € 2,918,741 First fiscal year in the series	€ 1,197,362 Cash 2023: € 1,197,362 ▼ 59% vs 2022 (€ 2,918,741) Unfavourable step	€ 522,736 Cash 2024: € 522,736 ▼ 56% vs 2023 (€ 1,197,362) Unfavourable step	€ 68,521 Cash 2025: € 68,521 ▼ 87% vs 2024 (€ 522,736) Unfavourable step	▼ 87%
Retained profit	€ 2,003,728 Retained profit 2022: € 2,003,728 First fiscal year in the series	€ 2,205,855 Retained profit 2023: € 2,205,855 ▲ 10% vs 2022 (€ 2,003,728) Favourable step	€ 2,473,912 Retained profit 2024: € 2,473,912 ▲ 12% vs 2023 (€ 2,205,855) Favourable step	€ 2,694,847 Retained profit 2025: € 2,694,847 ▲ 9% vs 2024 (€ 2,473,912) Favourable step	▲ 9%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 13,438 Bank debt 2025: € 13,438 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 3,120,971 Balance sheet total 2022: € 3,120,971 First fiscal year in the series	€ 3,388,031 Balance sheet total 2023: € 3,388,031 ▲ 9% vs 2022 (€ 3,120,971) Unchanged	€ 3,687,142 Balance sheet total 2024: € 3,687,142 ▲ 9% vs 2023 (€ 3,388,031) Unchanged	€ 3,986,406 Balance sheet total 2025: € 3,986,406 ▲ 8% vs 2024 (€ 3,687,142) Unchanged	▲ 8%

Key figures of Dr. I. Ameloot, Orthopedische heelkunde, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. I. Ameloot, Orthopedische heelkunde?

What happened at Dr. I. Ameloot, Orthopedische heelkunde in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 23, 2026 New annual accounts for financial year 2025: profit of € 220,935 (▼ 18% vs 2024). Source: NBB ↗
2023 Ivan Ameloot became a director. NBB
Oct 26, 1999 Start of the company according to the CBE. KBO
Oct 11, 1999 New establishment in Heusden-Zolder. KBO

In short

From € 245,924 profit in 2022 to € 220,935 profit in 2025.

Paid € 419,143 in corporate taxes since 2022.

Best year ever: 2024, with € 268,056 profit.

Original PDFs at the National Bank ↗

Management

Ivan Ameloot

Dr. I. Ameloot, Orthopedische heelkunde

Orthoteam Limburg

Behind Dr. I. Ameloot, Orthopedische heelkunde is Ivan Ameloot. Ivan Ameloot is also behind Orthoteam Limburg.

Directors

According to the 2025 annual accounts

Ivan Ameloot

Director

Also active at: Orthoteam Limburg

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Asselsstraat 100

9031 Gent

2.228.705.256

Pastoor Paquaylaan 129

3550 Heusden-Zolder

Active since 11 October 1999

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0467.137.152
VAT number: BE 0467.137.152
Registered office: Asselsstraat 100, 9031 Gent
Names & denominations: Dr. I. Ameloot, Orthopedische heelkunde
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 October 1999
Peppol: Active · Active since 2 Sept 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗